World STDs Diagnosis Market - Forecast(2024 - 2030)

Report Code: HCR 66001 Report Format: PDF + Excel

World STDs Diagnosis Market Overview

World STDs Diagnosis Market size is estimated to reach $141.4 billion by 2026, growing at a CAGR of 5.6% during the forecast period 2021-2026. Sexually transmitted diseases (STDs) are infections that spread from one person to another through sexual contact. These infections are caused by bacteria, viruses, and parasites. Sexually transmitted infections are an important global health priority concern owing to their devastating impact on women and infants. Infection with certain STDs also increases the risk of getting and transmitting human immunodeficiency viruses as well as alters the way the disease progresses. Rise in the prevalence of sexually transmitted infections caused by human immunodeficiency viruses and trichomonas vaginalis, growing awareness about the advantages provided by the point of care (PoC) testing devices, and increase in the implementation of national screening programs are the factors that are set to drive the growth of the World STDs Diagnosis Market for the period 2021-2026.

Report Coverage

The report: “World STDs Diagnosis Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the World STDs Diagnosis Market.
By Type: Gonorrhea Testing, Chlamydia Testing, Human Papilloma Virus (HPV) Testing, Chancroid Testing, P&S Syphilis Testing, and Human Immunodeficiency Virus (HIV) Testing.
By Location: Laboratory Testing and Point Of Care (PoC) Testing.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America World STDs Diagnosis Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing prevalence of sexually transmitted infections caused by human immunodeficiency viruses.
  • The rise in the demand for advanced testing devices for the treatment of chlamydia is driving the Chlamydia Testing segment. However, limited access to sexually transmitted infections diagnosis in developing nations is one of the major factors that is said to reduce the growth of the World STDs Diagnosis Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the World STDs Diagnosis Market report.

World STDs Diagnosis Market Size, By Type, 2020-2026 (USD Million)

World STDs Diagnosis Market

For More Details on This Report - Request for Sample

World STDs Diagnosis Market Segment Analysis-By Type

The World STDs Diagnosis Market based on the Type can be further segmented into Gonorrhea Testing, Chlamydia Testing, Human Papilloma Virus (HPV) Testing, Chancroid Testing, P&S Syphilis Testing, and Human Immunodeficiency Virus (HIV) Testing. The Chlamydia Testing segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 6.7% over the period 2021-2026. This growth is owing to the factors such as growing awareness about the complications related to the disease and increasing demand for advanced testing devices for the treatment of chlamydia. The rise in the adoption of diagnostic tests that are efficient in providing rapid results with high sensitivity for the treatment of chlamydia is driving the growth of the World STDs Diagnosis Market. The P&S Syphilis Testing segment held the second largest share in 2020 owing to the factors such as the growing prevalence of syphilis infections among bisexuals and increase in the incidence of weakened immune systems coupled with unprotected sex in developed nations.

World STDs Diagnosis Market Segment Analysis-By Location

The World STDs Diagnosis Market based on the Location can be further segmented into Laboratory Testing and Point Of Care (PoC) Testing. The Laboratory Testing segment held the largest share in 2020 owing to the factors such as growing demand for advanced laboratory testing devices and rise in the investment by the key players for expanding the services for the treatment of sexually transmitted infections. The rise in the demand for laboratory testing for the treatment of sexually transmitted infections caused by human immunodeficiency viruses and trichomonas vaginalis is driving the growth of the World STDs Diagnosis Market. The Point Of Care (PoC) Testing segment is estimated to be the fastest growing segment with a CAGR of 6.2% over the period 2021-2026. This growth is owing to the factors such as growing awareness about the advantages provided by the point of care (PoC) testing devices and increase in the inclination towards faster diagnosis in developed nations.

World STDs Diagnosis Market Segment Analysis-By Geography

North America held the largest share with 28% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing prevalence of syphilis infections among bisexuals and increase in the demand for faster diagnosis in developed nations. The rise in the prevalence of sexually transmitted infections caused by human immunodeficiency viruses is driving the growth of the World STDs Diagnosis Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing awareness about the advantages provided by the point of care (PoC) testing devices and rise in the prevalence of sexually transmitted infections caused by trichomonas vaginalis.

World STDs Diagnosis Market Drivers

Increase in the Implementation of National Screening Programs

With the increase in the prevalence of various sexually transmitted infections caused by human immunodeficiency viruses and trichomonas vaginalis, several countries across the globe are focusing on implementing national screening programs to expand the coverage of sexually transmitted infections diagnosis. Moreover, favorable reimbursement policies have also been implemented, which is propelling the growth of the World STDs Diagnosis Market.

Rise in the Prevalence of Gonorrhea

Gonorrhea is one of the most common bacterial sexually transmitted infections that results in substantial morbidity and economic cost worldwide. It can be easily passed between people through unprotected vaginal and anal sex. However, it is easily diagnosed by testing a sample of discharge, which is picked up using a swab. The rising burden of gonorrhea across the world is one of the major factors driving the growth of the World STDs Diagnosis Market.

World STDs Diagnosis Market Challenges

Limited Access to Sexually Transmitted Infections Diagnosis in Developing Nations

The governments of developed nations are focusing on the betterment of healthcare infrastructure and the introduction of advanced diagnostics infrastructure to provide precise testing results facilitating better treatment for sexually transmitted infections. However, limited access to sexually transmitted infections diagnosis in developing nations is one of the major factors that is estimated to reduce the growth of the World STDs Diagnosis Market.

World STDs Diagnosis Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the World STDs Diagnosis Market. Key companies of this market are Becton Dickinson and Company, Roche Holdings AG, Alere Inc, BioMerieux, Danaher Corporation, Abbott Laboratories, DiaSorin, Orasure, Quest Diagnostics, and Hologic Inc among others.

Partnerships/Product Launches:

  •  In June 2020, Roche Holdings and SpeeDx entered into a partnership to expand access to SpeeDx infectious disease and antibiotic resistance tests and technology to provide clinicians with tools for detecting resistance in patients with sexually transmitted infections.
  • In October 2019, Hologic Inc has launched new Aptima® BV and Aptima® CV/TV assays for the treatment of various complications, including a sexually transmitted infection (STI) such as chlamydia or HIV and pregnancy-related risks including premature delivery and low birth weight.
  • In April 2019, Quest Diagnostics has launched three new sexually transmitted disease (STD) laboratory test packages in the United States to meet the needs of individuals who want accurate basic and comprehensive STD testing.

Relevant Reports

Report Code: HCR 40147

Report Code: HCR 0085

For more Lifesciences and Healthcare Market reports, please click here

1. World STDs Diagnosis Market - Overview
    1.1 Definitions and Scope
2. World STDs Diagnosis Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Type
    2.3 Key trends by Location
    2.4 Key trends by Geography
3. World STDs Diagnosis Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. World STDs Diagnosis Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. World STDs Diagnosis Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. World STDs Diagnosis Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. World STDs Diagnosis Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. World STDs Diagnosis Market – By Type(Market Size –$Million/$Billion)
    8.1 Gonorrhea Testing
    8.2 Chlamydia Testing
    8.3 Human Papilloma Virus (HPV) Testing
    8.4 Chancroid Testing
    8.5 P&S Syphilis Testing
    8.6 Human Immunodeficiency Virus (HIV) Testing
9. World STDs Diagnosis Market – By Location(Market Size –$Million/$Billion)
    9.1 Laboratory Testing
    9.2 Point Of Care (POC) Testing
10. World STDs Diagnosis Market - By Geography(Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. World STDs Diagnosis Market - Entropy
12. World STDs Diagnosis Market – Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. World STDs Diagnosis Market – Key Company List by Country Premium Premium
14. World STDs Diagnosis Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 ($M)
1.1 CHLAMYDIA Market 2023-2030 ($M) - Global Industry Research
1.2 PS; SYPHILIS Market 2023-2030 ($M) - Global Industry Research
1.3 GONORRHEA Market 2023-2030 ($M) - Global Industry Research
1.4 HERPES SIMPLEX VIRUS Market 2023-2030 ($M) - Global Industry Research
1.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 ($M) - Global Industry Research
1.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 ($M) - Global Industry Research
1.7 CHANCROID Market 2023-2030 ($M) - Global Industry Research
2.Global STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 ($M)
2.1 LABORATORY Market 2023-2030 ($M) - Global Industry Research
2.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 ($M) - Global Industry Research
3.Global STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 ($M)
3.1 LABORATORY DEVICES Market 2023-2030 ($M) - Global Industry Research
3.1.1 PCRs Market 2023-2030 ($M)
3.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 ($M)
3.1.3 Flow Cytometers Market 2023-2030 ($M)
3.1.4 Differential Light Scattering Market 2023-2030 ($M)
3.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 ($M)
3.2 POC DEVICES Market 2023-2030 ($M) - Global Industry Research
3.2.1 Phone chips Market 2023-2030 ($M)
3.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 ($M)
4.Global STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 (Volume/Units)
4.1 CHLAMYDIA Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 PS; SYPHILIS Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 GONORRHEA Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 HERPES SIMPLEX VIRUS Market 2023-2030 (Volume/Units) - Global Industry Research
4.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 (Volume/Units) - Global Industry Research
4.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 (Volume/Units) - Global Industry Research
4.7 CHANCROID Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 (Volume/Units)
5.1 LABORATORY Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 (Volume/Units)
6.1 LABORATORY DEVICES Market 2023-2030 (Volume/Units) - Global Industry Research
6.1.1 PCRs Market 2023-2030 (Volume/Units)
6.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 (Volume/Units)
6.1.3 Flow Cytometers Market 2023-2030 (Volume/Units)
6.1.4 Differential Light Scattering Market 2023-2030 (Volume/Units)
6.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 (Volume/Units)
6.2 POC DEVICES Market 2023-2030 (Volume/Units) - Global Industry Research
6.2.1 Phone chips Market 2023-2030 (Volume/Units)
6.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 (Volume/Units)
7.North America STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 ($M)
7.1 CHLAMYDIA Market 2023-2030 ($M) - Regional Industry Research
7.2 PS; SYPHILIS Market 2023-2030 ($M) - Regional Industry Research
7.3 GONORRHEA Market 2023-2030 ($M) - Regional Industry Research
7.4 HERPES SIMPLEX VIRUS Market 2023-2030 ($M) - Regional Industry Research
7.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 ($M) - Regional Industry Research
7.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 ($M) - Regional Industry Research
7.7 CHANCROID Market 2023-2030 ($M) - Regional Industry Research
8.North America STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 ($M)
8.1 LABORATORY Market 2023-2030 ($M) - Regional Industry Research
8.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 ($M) - Regional Industry Research
9.North America STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 ($M)
9.1 LABORATORY DEVICES Market 2023-2030 ($M) - Regional Industry Research
9.1.1 PCRs Market 2023-2030 ($M)
9.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 ($M)
9.1.3 Flow Cytometers Market 2023-2030 ($M)
9.1.4 Differential Light Scattering Market 2023-2030 ($M)
9.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 ($M)
9.2 POC DEVICES Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Phone chips Market 2023-2030 ($M)
9.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 ($M)
10.South America STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 ($M)
10.1 CHLAMYDIA Market 2023-2030 ($M) - Regional Industry Research
10.2 PS; SYPHILIS Market 2023-2030 ($M) - Regional Industry Research
10.3 GONORRHEA Market 2023-2030 ($M) - Regional Industry Research
10.4 HERPES SIMPLEX VIRUS Market 2023-2030 ($M) - Regional Industry Research
10.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 ($M) - Regional Industry Research
10.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 ($M) - Regional Industry Research
10.7 CHANCROID Market 2023-2030 ($M) - Regional Industry Research
11.South America STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 ($M)
11.1 LABORATORY Market 2023-2030 ($M) - Regional Industry Research
11.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 ($M) - Regional Industry Research
12.South America STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 ($M)
12.1 LABORATORY DEVICES Market 2023-2030 ($M) - Regional Industry Research
12.1.1 PCRs Market 2023-2030 ($M)
12.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 ($M)
12.1.3 Flow Cytometers Market 2023-2030 ($M)
12.1.4 Differential Light Scattering Market 2023-2030 ($M)
12.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 ($M)
12.2 POC DEVICES Market 2023-2030 ($M) - Regional Industry Research
12.2.1 Phone chips Market 2023-2030 ($M)
12.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 ($M)
13.Europe STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 ($M)
13.1 CHLAMYDIA Market 2023-2030 ($M) - Regional Industry Research
13.2 PS; SYPHILIS Market 2023-2030 ($M) - Regional Industry Research
13.3 GONORRHEA Market 2023-2030 ($M) - Regional Industry Research
13.4 HERPES SIMPLEX VIRUS Market 2023-2030 ($M) - Regional Industry Research
13.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 ($M) - Regional Industry Research
13.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 ($M) - Regional Industry Research
13.7 CHANCROID Market 2023-2030 ($M) - Regional Industry Research
14.Europe STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 ($M)
14.1 LABORATORY Market 2023-2030 ($M) - Regional Industry Research
14.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 ($M) - Regional Industry Research
15.Europe STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 ($M)
15.1 LABORATORY DEVICES Market 2023-2030 ($M) - Regional Industry Research
15.1.1 PCRs Market 2023-2030 ($M)
15.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 ($M)
15.1.3 Flow Cytometers Market 2023-2030 ($M)
15.1.4 Differential Light Scattering Market 2023-2030 ($M)
15.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 ($M)
15.2 POC DEVICES Market 2023-2030 ($M) - Regional Industry Research
15.2.1 Phone chips Market 2023-2030 ($M)
15.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 ($M)
16.APAC STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 ($M)
16.1 CHLAMYDIA Market 2023-2030 ($M) - Regional Industry Research
16.2 PS; SYPHILIS Market 2023-2030 ($M) - Regional Industry Research
16.3 GONORRHEA Market 2023-2030 ($M) - Regional Industry Research
16.4 HERPES SIMPLEX VIRUS Market 2023-2030 ($M) - Regional Industry Research
16.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 ($M) - Regional Industry Research
16.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 ($M) - Regional Industry Research
16.7 CHANCROID Market 2023-2030 ($M) - Regional Industry Research
17.APAC STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 ($M)
17.1 LABORATORY Market 2023-2030 ($M) - Regional Industry Research
17.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 ($M) - Regional Industry Research
18.APAC STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 ($M)
18.1 LABORATORY DEVICES Market 2023-2030 ($M) - Regional Industry Research
18.1.1 PCRs Market 2023-2030 ($M)
18.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 ($M)
18.1.3 Flow Cytometers Market 2023-2030 ($M)
18.1.4 Differential Light Scattering Market 2023-2030 ($M)
18.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 ($M)
18.2 POC DEVICES Market 2023-2030 ($M) - Regional Industry Research
18.2.1 Phone chips Market 2023-2030 ($M)
18.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 ($M)
19.MENA STDS DIAGNOSIS MARKET, BY DISEASE TYPE Market 2023-2030 ($M)
19.1 CHLAMYDIA Market 2023-2030 ($M) - Regional Industry Research
19.2 PS; SYPHILIS Market 2023-2030 ($M) - Regional Industry Research
19.3 GONORRHEA Market 2023-2030 ($M) - Regional Industry Research
19.4 HERPES SIMPLEX VIRUS Market 2023-2030 ($M) - Regional Industry Research
19.5 HUMAN PAPILLOMA VIRUS Market 2023-2030 ($M) - Regional Industry Research
19.6 HUMAN IMMUNODEFICIENCY VIRUS Market 2023-2030 ($M) - Regional Industry Research
19.7 CHANCROID Market 2023-2030 ($M) - Regional Industry Research
20.MENA STDS DIAGNOSIS MARKET, BY LOCATION OF DIAGNOSIS Market 2023-2030 ($M)
20.1 LABORATORY Market 2023-2030 ($M) - Regional Industry Research
20.2 POINT-OF-CARE DIAGNOSIS Market 2023-2030 ($M) - Regional Industry Research
21.MENA STDS DIAGNOSIS MARKET, BY DEVICE TYPE Market 2023-2030 ($M)
21.1 LABORATORY DEVICES Market 2023-2030 ($M) - Regional Industry Research
21.1.1 PCRs Market 2023-2030 ($M)
21.1.2 Immunochromatographic capillary flow dipstick technology Market 2023-2030 ($M)
21.1.3 Flow Cytometers Market 2023-2030 ($M)
21.1.4 Differential Light Scattering Market 2023-2030 ($M)
21.1.5 Enzyme Linked Immunosorbent Assay Market 2023-2030 ($M)
21.2 POC DEVICES Market 2023-2030 ($M) - Regional Industry Research
21.2.1 Phone chips Market 2023-2030 ($M)
21.2.2 Portable / bench top / rapid diagnostic kits Market 2023-2030 ($M)

LIST OF FIGURES

1.US World STDs Diagnosis Market Revenue, 2023-2030 ($M)
2.Canada World STDs Diagnosis Market Revenue, 2023-2030 ($M)
3.Mexico World STDs Diagnosis Market Revenue, 2023-2030 ($M)
4.Brazil World STDs Diagnosis Market Revenue, 2023-2030 ($M)
5.Argentina World STDs Diagnosis Market Revenue, 2023-2030 ($M)
6.Peru World STDs Diagnosis Market Revenue, 2023-2030 ($M)
7.Colombia World STDs Diagnosis Market Revenue, 2023-2030 ($M)
8.Chile World STDs Diagnosis Market Revenue, 2023-2030 ($M)
9.Rest of South America World STDs Diagnosis Market Revenue, 2023-2030 ($M)
10.UK World STDs Diagnosis Market Revenue, 2023-2030 ($M)
11.Germany World STDs Diagnosis Market Revenue, 2023-2030 ($M)
12.France World STDs Diagnosis Market Revenue, 2023-2030 ($M)
13.Italy World STDs Diagnosis Market Revenue, 2023-2030 ($M)
14.Spain World STDs Diagnosis Market Revenue, 2023-2030 ($M)
15.Rest of Europe World STDs Diagnosis Market Revenue, 2023-2030 ($M)
16.China World STDs Diagnosis Market Revenue, 2023-2030 ($M)
17.India World STDs Diagnosis Market Revenue, 2023-2030 ($M)
18.Japan World STDs Diagnosis Market Revenue, 2023-2030 ($M)
19.South Korea World STDs Diagnosis Market Revenue, 2023-2030 ($M)
20.South Africa World STDs Diagnosis Market Revenue, 2023-2030 ($M)
21.North America World STDs Diagnosis By Application
22.South America World STDs Diagnosis By Application
23.Europe World STDs Diagnosis By Application
24.APAC World STDs Diagnosis By Application
25.MENA World STDs Diagnosis By Application
26.F. HOFFMANN-LA ROCHE AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.BIOMRIEUX SA, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.HOLOGIC, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.BECTON DICKINSON COMPANY, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.CEPHEID, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.DANAHER CORPORATION, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.AFFYMETRIX, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.ALERE INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.ABBOTT LABORATORIES, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.DIASORIN S.P.A., Sales /Revenue, 2015-2018 ($Mn/$Bn)